Acute Viral Bronchiolitis Clinical Trial
Official title:
Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis
The aim of the investigators study is to compare in children aged less than 18 months and hospitalized for an acute viral bronchiolitis the efficacy of the HS 3% (Mucoclear®, sterile ampoules of 4 ml) nebulised with a conventional jet-nebulizer (particles diameter of 4-5 µm), or with a jet-nebulizer adapted for infants (particles diameter of 2-2.5 µm), or with a mesh-nebulizer adapted for infants (particles diameter of 2-2.5 µm).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01777347 -
Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis
|
Phase 3 | |
Not yet recruiting |
NCT01437956 -
KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis
|
N/A | |
Completed |
NCT01873144 -
High Flow Therapy vs Hypertonic Saline in Bronchiolitis
|
Phase 3 | |
Completed |
NCT05899894 -
NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study
|
N/A | |
Completed |
NCT02460614 -
Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis
|
N/A | |
Completed |
NCT03738501 -
Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis
|
N/A | |
Recruiting |
NCT03976895 -
Prone Position in Acute Bronchiolitis
|
N/A |